Hypolipidemics reduce the rate of Alzheimer's disease development and dementia progression: A cohort study linked with genetic and neuropathological analyses | Synapse
April 16, 2026The Journal of Prevention of Alzheimer s Disease1 citationsOpen Access
Hypolipidemics reduce the rate of Alzheimer's disease development and dementia progression: A cohort study linked with genetic and neuropathological analyses
This research aims to explore the effects of hypolipidemic treatment on the development of Alzheimer's disease and dementia progression.
Cohort study design linking genetic and neuropathological analyses
Evaluation of hypolipidemic treatment effects on cognitive functionality
Assessment of dementia progression based on various etiologies
Hypolipidemics were associated with a reduced rate of Alzheimer's disease development
Dementia progression was significantly slowed in individuals receiving hypolipidemic treatment
Cognitive dysfunction was delayed regardless of the underlying cause
Abstract
Our results have implications for delaying cognitive dysfunction and halting the progression of dementia, regardless of the etiology being related to AD or vascular pathology.